Smart Insulin Pen Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	105 Pages	Coherent Market Insights	July, 2023	CMI18107979

Best Price Guarantee
Price	from $4,500
Length	105 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107979

Smart Insulin Pen Market, By Indication (Type 1 Diabetes, Type 2 Diabetes), By Connectivity (Bluetooth, USB), By Distribution Channel (Clinics and Ambulatory Surgical Centers, e-Commerce, Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

A smart insulin pen is a reusable injector pen with an intuitive smartphone app that can help people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts, and reports. They can come in the form of an add-on to current insulin pen or a reusable form which uses prefilled cartridges instead of vials or disposable pens. The first insulin pen devices were introduced in the late 1980s as an alternative to vials and syringes. They allowed for more accurate dosing, better adherence, and less injection site pain. As these devices evolved, they gained digital displays and memory of the most recent insulin doses. Eventually, data tracking attachments were developed to help disposable insulin pens keep better track of doses. Glucose sensing, continuous glucose monitoring, dosage timing, reminders, and other advancements followed. The first U.S. Food and Drug Administration (FDA)–cleared reusable smart insulin pen was launched in 2017. Smart pens are designed to be simple to use. Once the app is downloaded to smartphone and paired it with insulin pen, it is ready to go. The device sends real-time data to the app via Bluetooth connection.

Market Dynamics

Increasing prevalence of diabetes worldwide, adoption of growth strategies such as acquisitions and mergers from key market players, introduction of newer insulin products and research and development activities are driving the growth of global smart insulin pen market. For instance, in August 12, 2020, Medtronics, a U.S.-based medical service company, announced the planned acquisition of Companion Medical, a U.S.-based medical devices manufacturer, who is a manufacturer of InPen- a U.S. Food and Drug Administration cleared smart insulin pen system paired with an integrated diabetes management app.

Key features of the study:

This report provides an in-depth analysis of the global smart insulin pen market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global smart insulin pen market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, Companion Medical Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Pendiq GmbH, Sanofi, Berlin Chemie Companion Medical Inc., Bigfoot Biomedical, Digital Medics Pty ltd, Eli Lilly and company, Ypsomed Holding AG, Diabnext Diamesco Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global smart insulin pen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart insulin pen market

Detailed Segmentation:

Global Smart Insulin Pen Market, By Indication:
Type 1 Diabetes
Type 2 Diabetes
Global Smart Insulin Pen Market, By Connectivity :
Bluetooth
USB
Global Smart Insulin Pen Market, By Distribution Channel:
Clinics and Ambulatory Surgical Centers
e-Commerce
Retail Pharmacies
Global Smart Insulin Pen Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Digital Medics Pty. Ltd.
Emperra GmbH E-Health Technologies
Novo Nordisk
Companion Medical Inc.
Jiangsu Deflu Medical Device Co. Ltd.
Medtronic PLC
Pendiq GmbH
Sanofi
Berlin Chemie Companion Medical Inc.
Bigfoot Biomedical
Digital Medics Pty Ltd
Eli Lilly and company
Ypsomed Holding AG
Diabnext Diamesco Co. Ltd.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Indication; Market Snapshot, By Connectivity; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Smart Insulin Pen Market – COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Smart Insulin Pen Market, By Indication, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019–2030; Segment Trends; Type 1 Diabetes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Type 2 Diabetes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
6. Global Smart Insulin Pen Market, By Connectivity, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019–2030; Segment Trends; Bluetooth; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); USB; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Smart Insulin Pen Market, By Distribution Channel, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2019–2030; Segment Trends; Clinics and Ambulatory Surgical Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); e-Commerce; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
8. Global Smart Insulin Pen Market, By Region, 2018 – 2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Regions, 2019–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); North Africa; Central Africa; South Africa
9. Competitive Landscape: Digital Medics Pty. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Emperra GmbH E-Health Technologies; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Novo Nordisk; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Companion Medical Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Jiangsu Deflu Medical Device Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Medtronic PLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Pendiq GmbH; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Sanofi; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Berlin Chemie Companion Medical Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bigfoot Biomedical; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Digital Medics Pty Ltd; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Eli Lilly and company; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Ypsomed Holding AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Diabnext Diamesco Co. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
10. Section: Research Methodology; About Us; *Browse 35 market data tables and 25 figures on “Global Smart Insulin Pen Market” - Global forecast to 2030